Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 43

Sort by

Sort Order Select

Journal Articles

The Changing Face of B-Cell Lymphoma in the Anti-Retroviral Therapy Era in South Africa

Tracey Monica Wiggill, MD MBBS, Elizabeth Sarah Mayne, MBBCh, FC Path(SA) Haem, MMed (Haem), Yvonne Perner, MBBCh, FC Path(SA) Anat, MMed (Anat), Jenifer Vaughan, MBBCh, FC Path(SA) Haem, MMed (Haem)

Blood (2019) 134 (Supplement_1): 3418.

https://doi.org/10.1182/blood-2019-126961

Published: 2019

Journal Articles

Real-World Treatment Patterns, Health-Care Costs and Predictors for TKI Changes in CML: Results from a Population Representative German Claims Data Analysis

Susanne Saussele, MD, Katharina Kohlbrenner, PhD, Thomas Kaworski, Tobias Vogelmann, MSc, Tino Schubert, MSc

Blood (2019) 134 (Supplement_1): 1645.

https://doi.org/10.1182/blood-2019-122649

Published: 2019

Journal Articles

Etiologies and Predictors of 30-Day Readmission in Patients Undergoing Induction Chemotherapy for Acute Myeloid Leukemia

Shivani Handa, MBBS, Kamesh Gupta, MBBS, Jasdeep Singh Sidhu, MBBS, Giulia Petrone, MD MBBS, Sridevi Rajeeve, MD, Karan Jatwani, MBBS

Blood (2019) 134 (Supplement_1): 4759.

https://doi.org/10.1182/blood-2019-132180

Published: 2019

Journal Articles

Characteristics of Sickle Cell Clinic Visits and Hospital Admissions in a Large Urban Academic Hospital

Levani Odikadze, MD MPH, Morgan L. McLemore, MD, Neli Stoyanova, MD, Fuad A El Rassi, MD

Blood (2019) 134 (Supplement_1): 5857.

https://doi.org/10.1182/blood-2019-131133

Published: 2019

Journal Articles

Level of Utilization and Provider-Related Barriers to Hydroxyurea Use in the Treatment of Sickle Cell Disease in Jos, Nigeria

Akinyemi Olugbenga David Ofakunrin, MBBS, Kehinde Adekola, MD MS, Edache Sylvanus Okpe, MBBS, FWACP, Stephen Oguche, MBBS, FMCPaed, Tolulope Afolaranmi, MBBS, FWACP, Patience Kanhu, MBBS, FMCPaed, Nantok Dami, MBBS, Atiene Solomon Sagay, MBBS, FMCOG, FRCOG

Blood (2019) 134 (Supplement_1): 1029.

https://doi.org/10.1182/blood-2019-128185

Published: 2019

Journal Articles

Is There a Role for Thromboprophylaxis in Sickle Cell Patients with Central Venous Access Devices?

Stéphanie Forté, MD MSc, FRCPC, Nafanta Fadiga, Olivia Pestrin, John Chinawaeze Aneke, MBBS, FMCPath, Shivani Bhat, MPH, Richard Ward, MBBS, MRCP, Kevin H. M. Kuo, MD MSc, FRCPC

Blood (2018) 132 (Supplement 1): 3518.

https://doi.org/10.1182/blood-2018-99-119716

Published: 2018

Journal Articles

Longer Distance to a Specialized Treatment Center Does Not Adversely Affect Access to Treatment or Outcome in Acute Myeloid Leukemia: A National Population-Based Cohort Study

Michael Buch Tostesen, MD, Jan M. Norgaard, MD PhD, Mette Nørgaard, MD PhD, Bruno C. Medeiros, MD, Claus Werenberg Marcher, MD PhD, Ulrik Malthe Overgaard, MD, Claudia Schöllkopf, MD PhD, Marianne Tang Severinsen, MD PhD, Lene Sofie Granfeldt Oestgaard, MDPhD

Blood (2018) 132 (Supplement 1): 613.

https://doi.org/10.1182/blood-2018-99-110922

Published: 2018

Journal Articles

Association between Employment Status and Hospitalization of Patients with Sickle Cell Disease: A Retrospective, Observational Pilot Study

Modupe Idowu, MD, Tong Han Chung, PhD, Katherine Yu

Blood (2018) 132 (Supplement 1): 4930.

https://doi.org/10.1182/blood-2018-99-120136

Published: 2018

Journal Articles

Reduced Hospitalization with Establishment of a Multidisciplinary Clinic for Patients with Sickle Cell Disease

Christopher Mogish Terry, MD, Robert A. Sokolic, MD, Katie Cherenzia, RN

Blood (2018) 132 (Supplement 1): 4931.

https://doi.org/10.1182/blood-2018-99-120138

Published: 2018

Journal Articles

An Increasing Trend of Incidence, Prevalence and Mortality, and Occurrence of Second Primary Malignancies Among Patients with B-Cell Non-Hodgkin Lymphoma: A 10-Year Longitudinal Population-Based Retrospective Cohort Study in South Korea

Jin Seok Kim, MD, PhD, Yanfang Liu, MD MPH, Kyoung Hwa Ha, PhD, Hong Qiu, MD PhD, Lee Anne Rothwell, PhD, Yu Ri Kim, MD, Hyeon Chang Kim, MD PhD

Blood (2018) 132 (Supplement 1): 2991.

https://doi.org/10.1182/blood-2018-99-110418

Published: 2018

Journal Articles

Monoclonal Gammopathies: Electronic Subspecialty Consultation

Nicholas Burwick, MD, Jacob Stein, David A Garcia, MD, Virginia C. Broudy, MD, Robert E. Richard, MD PhD

Blood (2017) 130 (Supplement 1): 673.

https://doi.org/10.1182/blood.V130.Suppl_1.673.673

Published: 2017

Journal Articles

Peripheral Neuropathy Is an Under-Recognized Feature of Monoclonal Gammopathy of Undetermined Significance: A Population-Based Study of 18,668 MGUS Patients and Their 97,641 Matched Controls

Sæmundur Rögnvaldsson, Vilhjálmur Steingrímsson, MD, Ingemar Turesson, MD PhD, Magnus Björkholm, MD PhD, Ola Landgren, MD PhD, Sigurður Yngvi Kristinsson, MD PhD

Blood (2017) 130 (Supplement 1): 4338.

https://doi.org/10.1182/blood.V130.Suppl_1.4338.4338

Published: 2017

Journal Articles

Protective Environment for Hematopoietic Cell Transplant (HSCT) Recipients: The Infectious Diseases Working Party EBMT Analysis of Global Recommendations on Health-Care Facilities

Jan Styczynski, MDPhD, Simona Iacobelli, Peter Donnelly, Gloria Tridello, Jennifer Hoek, Malgorzata Mikulska, Simone Cesaro

Blood (2017) 130 (Supplement 1): 3398.

https://doi.org/10.1182/blood.V130.Suppl_1.3398.3398

Published: 2017

Journal Articles

Beta-Thalassemia (BT) Prevalence and Treatment Patterns in Italy: A Survey of Treating Physicians

Emanuele Angelucci, MD, Nigel Burrows, Stefano Losi, Chris Bartiromo, X. Henry Hu, MD PhD

Blood (2016) 128 (22): 3533.

https://doi.org/10.1182/blood.V128.22.3533.3533

Published: 2016

Journal Articles

It Is Safe to Change Horses in the Midstream - 3-Year Experience of Treating CML Patients with Imatinib Generics

Vasily Shuvaev, MD, Mikhail Fominykh, MD, Vera Udaleva, MD, Irina I Zotova, MD, Regina Golovchenko, MD PhD, Dzhariyat Shikhbabaeva, MD, Irina Martynkevich, DSc, Lyudmila Martynenko, Marina Ivanova, MD PhD, Natalya Tsybakova, PhD, Ekaterina Motyko, PhD, Lyubov Polushkina, MD, Nadezhda Potikhonova, MD PhD, Sophya Tyranova, MD PhD, Marina Zenina, MD PhD, Kudrat Abdulkadyrov, MD PhD

Blood (2016) 128 (22): 5442.

https://doi.org/10.1182/blood.V128.22.5442.5442

Published: 2016

Journal Articles

Improved Survival of Older Patients with Mantle Cell Lymphoma (MCL) with Front-Line Cytarabine-Based Immunochemotherapy

Sumita Ratnasingam, MBBS, Michael Gilbertson, Zoe McQuilten, MBBS, Kay T Htun, George Grigoriadis, MBBS, PhD BSc, Swe Myo Htet, MBBS, Philip Campbell, MBBS, FRACP, FRCPA, Khai Li Chai, MBBS, Hang Quach, MBBS (Hons), FRACP, FRCPA, MD, Sushrut S. Patil, FRACP, FRCPA, Jake Shortt, MD, Stephen Opat, MD

Blood (2016) 128 (22): 2965.

https://doi.org/10.1182/blood.V128.22.2965.2965

Published: 2016

Journal Articles

Barriers to Implementation of Evidence-Based Stroke Prevention in Sickle Cell Disease: A Preliminary Study

Alyssa M Schlenz, PhD, Joannie Hayes, MD, Martina Mueller, PhD, Shannon Hudson, PhD, R.N., Robert J. Adams, MD MS, Julie Kanter, MD

Blood (2015) 126 (23): 749.

https://doi.org/10.1182/blood.V126.23.749.749

Published: 2015

Journal Articles

A Clinic to Improve Care of Patients with Sickle Cell Disease and the Role of Medical Students in Quality Improvement

Annie Press, Robert Lucito, PhD, Ilene Friedman, MD, Samara Ginzburg, MD

Blood (2015) 126 (23): 5586.

https://doi.org/10.1182/blood.V126.23.5586.5586

Published: 2015

Journal Articles

Clostridium Difficile Infection in Haematology Patients Significantly Increases Length of Stay; A Case Control Study

Louise Imlay-Gillespie, BMed, Caroline Dix, MBBS, Ashley McEwan, MD, Kelly Wong, Melanie Figtree, MBBS, Christopher Arthur, MD, Luke Coyle, MBBS, FRACP, FRCPA, Keith Fay, MBChB FRACP FRCPA, Matthew Greenwood, MBBS, FRACP, FRCPA, Naomi Mackinlay, MBBS, FRACP, FRCPA, Stephen Mulligan, MBBS, PhD FRACP, FRCPA, William Stevenson, MBBS, PhD, Christopher M Ward, MBChB, PhD FRACP, FRCPA, Ian H. Kerridge, MBBS, MPhil, FRACP, FRCPA

Blood (2015) 126 (23): 2108.

https://doi.org/10.1182/blood.V126.23.2108.2108

Published: 2015

Journal Articles

Health Care Utilization and End of Life Care for Older Patients with Acute Myeloid Leukemia Receiving Supportive Care Alone

Areej El-Jawahri, MD, Sean F. Heavey, BS, Thomas W. LeBlanc, MD MA, Harry Vandusen, BS, Gregory Abel, MD MPH, David P. Steensma, MD, Lara Traeger, PhD, Amir T. Fathi, MD, Daniel J. DeAngelo, MD PhD, Martha Wadleigh, MD, Gabriela Hobbs, MD, Philip C. Amrein, MD, Richard M. Stone, MD, Karen K. Ballen, MD, Yi-Bin Chen, MD, Jennifer S. Temel, MD

Blood (2015) 126 (23): 2126.

https://doi.org/10.1182/blood.V126.23.2126.2126

Published: 2015

NARROW

The Changing Face of B-Cell Lymphoma in the Anti-Retroviral Therapy Era in South Africa

Real-World Treatment Patterns, Health-Care Costs and Predictors for TKI Changes in CML: Results from a Population Representative German Claims Data Analysis

Etiologies and Predictors of 30-Day Readmission in Patients Undergoing Induction Chemotherapy for Acute Myeloid Leukemia

Characteristics of Sickle Cell Clinic Visits and Hospital Admissions in a Large Urban Academic Hospital

Level of Utilization and Provider-Related Barriers to Hydroxyurea Use in the Treatment of Sickle Cell Disease in Jos, Nigeria

Is There a Role for Thromboprophylaxis in Sickle Cell Patients with Central Venous Access Devices?

Longer Distance to a Specialized Treatment Center Does Not Adversely Affect Access to Treatment or Outcome in Acute Myeloid Leukemia: A National Population-Based Cohort Study

Association between Employment Status and Hospitalization of Patients with Sickle Cell Disease: A Retrospective, Observational Pilot Study

Reduced Hospitalization with Establishment of a Multidisciplinary Clinic for Patients with Sickle Cell Disease

An Increasing Trend of Incidence, Prevalence and Mortality, and Occurrence of Second Primary Malignancies Among Patients with B-Cell Non-Hodgkin Lymphoma: A 10-Year Longitudinal Population-Based Retrospective Cohort Study in South Korea

Monoclonal Gammopathies: Electronic Subspecialty Consultation

Peripheral Neuropathy Is an Under-Recognized Feature of Monoclonal Gammopathy of Undetermined Significance: A Population-Based Study of 18,668 MGUS Patients and Their 97,641 Matched Controls

Protective Environment for Hematopoietic Cell Transplant (HSCT) Recipients: The Infectious Diseases Working Party EBMT Analysis of Global Recommendations on Health-Care Facilities

Beta-Thalassemia (BT) Prevalence and Treatment Patterns in Italy: A Survey of Treating Physicians

It Is Safe to Change Horses in the Midstream - 3-Year Experience of Treating CML Patients with Imatinib Generics

Improved Survival of Older Patients with Mantle Cell Lymphoma (MCL) with Front-Line Cytarabine-Based Immunochemotherapy

Barriers to Implementation of Evidence-Based Stroke Prevention in Sickle Cell Disease: A Preliminary Study

A Clinic to Improve Care of Patients with Sickle Cell Disease and the Role of Medical Students in Quality Improvement

Clostridium Difficile Infection in Haematology Patients Significantly Increases Length of Stay; A Case Control Study

Health Care Utilization and End of Life Care for Older Patients with Acute Myeloid Leukemia Receiving Supportive Care Alone

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only